| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |